BioRestorative Therapies, Inc.
USD0.37
-0.02 (-6.19%)
CEO
Lance Alstodt
IPO Date
2012-12-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.39
Prev. Close
$0.39
Day Low
$0.37
Day High
$0.39
52W Low
$0.16
52W High
$1.89
Market Cap
$0.00B
Volume
0.30M
| $0.00 |
| 17 Jun 2026 | Field Katharyn | director: | Disposed | 0 | $0.00 |
| 20 Oct 2025 | Silva Francisco | director, officer: VP of Research and Development | A-Award | Acquired | 11,719 | $1.60 |
| 20 Oct 2025 | Silva Francisco | director, officer: VP of Research and Development | A-Award | Acquired | 11,719 | $2.75 |
| 20 Oct 2025 | ALSTODT LANCE | director, 10 percent owner, officer: President, CEO, COB | A-Award | Acquired | 15,625 | $1.60 |
| 20 Oct 2025 | ALSTODT LANCE | director, 10 percent owner, officer: President, CEO, COB | A-Award | Acquired | 11,719 | $2.75 |
| 19 Feb 2025 | Silva Francisco | director, officer: VP of Research and Development | A-Award | Acquired | 768,979 | $2.46 |
| 19 Feb 2025 | Kukekov Nickolay V. | director | A-Award | Acquired | 52,632 | $2.46 |
| 19 Feb 2025 | Rosa David A | director | A-Award | Acquired | 52,632 | $2.46 |